Roanoke Times Copyright (c) 1995, Landmark Communications, Inc. DATE: THURSDAY, April 19, 1990 TAG: 9004190652 SECTION: NATIONAL/INTERNATIONAL PAGE: A9 EDITION: EVENING SOURCE: DATELINE: BOSTON LENGTH: Short
The drug - called 2-chlorodeoxyadenosine, or 2-CdA - has produced complete remissions in almost all hairy cell leukemia patients treated, and none has relapsed so far.
The drug also has been used successfully against chronic lymphocytic leukemia. It, like hairy cell leukemia, is a cancer of the white blood cells, which produce disease-fighting antibodies.
The latest study, published in today's New England Journal of Medicine, was directed by Dr. Lawrence Piro of the Scripps Clinic and Research Foundation in La Jolla, Calif.
In the published work, doctors gave the drug to 12 patients as far back as four years ago. In 11, the disease disappeared and they remain disease-free.
- Associated Press
by CNB